Overview

• Professor Richard Scolyer, diagnosed with aggressive glioblastoma in 2023, has revealed further tumor progression following its recurrence earlier this year.
• An MRI conducted on May 19, 2025, confirmed additional growth despite prior experimental immunotherapy and a March surgery to remove portions of the tumor.
• Scolyer's self-administered melanoma-based immunotherapy extended his survival for 18 months, a groundbreaking effort in glioblastoma treatment research.
• Jointly named Australian of the Year in 2024, Scolyer continues to advocate for advancing cancer therapies and remains optimistic about upcoming treatment options.
• Supported by family and friends, he remains committed to his personal and professional mission, expressing hope for another operation and future therapies.